Bemiparin: Difference between revisions

Jump to navigation Jump to search
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
No edit summary
Line 28: Line 28:
{{CMG}}
{{CMG}}


==Overview==
'''Bemiparin''' is an antithrombotic and belongs to the group of [[low molecular weight heparin]]s (LMWH).<ref>{{cite journal |author=Chapman TM, Goa KL |title=Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis |journal=Drugs |volume=63 |issue=21 |pages=2357–77 |year=2003 |pmid=14524738 |doi=10.2165/00003495-200363210-00009}}</ref>


Like semuloparin, bemiparin is classified as an ultra-LMWH because of its low [[molecular mass]] of 3600 [[Dalton (unit)|Daltons]] on average.<ref>{{cite pmid|12943485}}</ref> ([[Enoxaparin]] has 4500 Daltons.) These heparins have lower anti-[[thrombin]] activity than classical LMWHs and act mainly on [[factor Xa]], reducing the risk of bleeding.<ref>{{cite pmid|21458847}}</ref>


==Overview==
==External Links==
'''Bemiparin''' is an antithrombotic  in the [[heparin]] group.
 
==External links==
* {{cite journal |author=Chapman TM, Goa KL |title=Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis |journal=Drugs |volume=63 |issue=21 |pages=2357-77 |year=2003 |pmid=14524738 |doi=}}
* {{cite journal |author=Chapman TM, Goa KL |title=Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis |journal=Drugs |volume=63 |issue=21 |pages=2357-77 |year=2003 |pmid=14524738 |doi=}}
* {{MeshName|bemiparin}}
* {{MeshName|bemiparin}}
==References==
{{reflist|2}}


{{Antithrombotics}}
{{Antithrombotics}}


[[Category:Drugs]]
[[Category:Drug]]
{{WikiDoc Help Menu}}
[[Category:Cardiovascular Drugs]]
{{WikiDoc Sources}}
[[Category:Anticoagulants]]

Revision as of 00:55, 26 July 2014

Bemiparin
Clinical data
ATC code
Identifiers
CAS Number
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).

WikiDoc Resources for Bemiparin

Articles

Most recent articles on Bemiparin

Most cited articles on Bemiparin

Review articles on Bemiparin

Articles on Bemiparin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Bemiparin

Images of Bemiparin

Photos of Bemiparin

Podcasts & MP3s on Bemiparin

Videos on Bemiparin

Evidence Based Medicine

Cochrane Collaboration on Bemiparin

Bandolier on Bemiparin

TRIP on Bemiparin

Clinical Trials

Ongoing Trials on Bemiparin at Clinical Trials.gov

Trial results on Bemiparin

Clinical Trials on Bemiparin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Bemiparin

NICE Guidance on Bemiparin

NHS PRODIGY Guidance

FDA on Bemiparin

CDC on Bemiparin

Books

Books on Bemiparin

News

Bemiparin in the news

Be alerted to news on Bemiparin

News trends on Bemiparin

Commentary

Blogs on Bemiparin

Definitions

Definitions of Bemiparin

Patient Resources / Community

Patient resources on Bemiparin

Discussion groups on Bemiparin

Patient Handouts on Bemiparin

Directions to Hospitals Treating Bemiparin

Risk calculators and risk factors for Bemiparin

Healthcare Provider Resources

Symptoms of Bemiparin

Causes & Risk Factors for Bemiparin

Diagnostic studies for Bemiparin

Treatment of Bemiparin

Continuing Medical Education (CME)

CME Programs on Bemiparin

International

Bemiparin en Espanol

Bemiparin en Francais

Business

Bemiparin in the Marketplace

Patents on Bemiparin

Experimental / Informatics

List of terms related to Bemiparin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Bemiparin is an antithrombotic and belongs to the group of low molecular weight heparins (LMWH).[1]

Like semuloparin, bemiparin is classified as an ultra-LMWH because of its low molecular mass of 3600 Daltons on average.[2] (Enoxaparin has 4500 Daltons.) These heparins have lower anti-thrombin activity than classical LMWHs and act mainly on factor Xa, reducing the risk of bleeding.[3]

External Links

  • Chapman TM, Goa KL (2003). "Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis". Drugs. 63 (21): 2357–77. PMID 14524738.
  • bemiparin at the US National Library of Medicine Medical Subject Headings (MeSH)

References

  1. Chapman TM, Goa KL (2003). "Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis". Drugs. 63 (21): 2357–77. doi:10.2165/00003495-200363210-00009. PMID 14524738.
  2. PMID 12943485 (PMID 12943485)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
  3. PMID 21458847 (PMID 21458847)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand